Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Warren, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Bellerophon Therapeutics, Inc. has filed 643 SEC EDGAR filings since 21 Feb 2014

SEC filing history

Showing 401-425 of 643 matching filings.

Per page
25
Current page
17
4

FORM 4

Filing date
26 Sep 2017
Reporting date
22 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Sep 2017
Reporting date
22 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Sep 2017
Reporting date
22 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Sep 2017
Reporting date
22 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Sep 2017
Reporting date
22 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Sep 2017
Reporting date
22 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Sep 2017
Reporting date
22 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-36845

8-K/A

Filing date
15 Sep 2017
Reporting date
08 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
14 Sep 2017
Reporting date
08 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
05 Sep 2017
Reporting date
05 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
07 Aug 2017
Reporting date
07 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-219387

S-8

Filing date
21 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jul 2017
Reporting date
28 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jul 2017
Reporting date
28 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Jun 2017
Reporting date
28 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Jun 2017
Reporting date
28 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Jun 2017
Reporting date
28 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Jun 2017
Reporting date
28 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
22 May 2017
Reporting date
22 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 May 2017
Reporting date
17 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-287121

D filing

Filing date
19 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88741

SC 13G

Filing date
18 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
15 May 2017
Reporting date
15 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .